Innovating Regenerative & Immune-Based Therapies for the Future of Medicine
A Malaysian-based biopharmaceutical startup developing GMP-grade stem cell, exosome, and immunotherapy platforms for clinical use.
What We're Building
Modular GMP cleanroom facility (design approved)
Scalable biotherapeutic manufacturing
Translational research and tech transfer pipeline
Strategic collaborations with clinicians and research hubs
Mission and vision
At HopeStem, we believe the future of medicine lies in regenerative and immune-based therapies. Our mission is to advance this frontier by producing and delivering high-quality, NPRA-compliant GMP stem cell products, exosomes, and personalized cell- and gene-based therapeutic solutions for both clinical and commercial use. In addition to providing direct clinical services, we are deeply committed to pioneering research that enhances the safety, efficacy, and accessibility of regenerative treatments. Beyond addressing today’s medical challenges, we strive to shape a healthier, stronger, and more resilient future for generations to come.
GMP-Grade Stem Cell Manufacturing
(Autologous & Allogeneic MSCs, Wharton’s Jelly, Adipose, Bone Marrow)
Exosome-Based Therapeutics
(Anti-inflammatory, regenerative, and cosmetic applications)
Cell & Gene Immunotherapies
(Including CAR-modified cells and immune modulation)
Clinical-Grade Bioproducts
(Ready-to-infuse, tested, NPRA-compliant therapeutic batches)
Collaborative Translational Research
(With hospitals, universities, and CROs)
Cell & Gene Immunotherapies
(Including CAR-modified cells and immune modulation)